Potential of anti-amyloid therapies for patients with Alzheimer disease in Canada

Can Fam Physician. 2024 Sep;70(9):537-538. doi: 10.46747/cfp.7009537.
No abstract available

MeSH terms

  • Alzheimer Disease* / drug therapy
  • Alzheimer Disease* / therapy
  • Amyloid beta-Peptides
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Canada
  • Humans

Substances

  • Antibodies, Monoclonal, Humanized
  • Amyloid beta-Peptides
  • aducanumab